| Date | Title | Description |
| 30.04.2024 | TriSalus Life Sciences Secures up to $50 Million of Debt Fin... | DENVER–(BUSINESS WIRE)–Apr. 30, 2024– TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced t... |
| 30.04.2024 | Neurolenses Proven to Reduce Headache Symptoms | Report highlights the data from the recently published double-masked, randomized Headache Study. Bas... |
| 30.04.2024 | Truvaga™ Plus Demonstrates Health Benefits in Latest Consume... | ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR),... |
| 26.04.2024 | Exagen Inc. Announces Changes to the Board of Directors | CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of... |
| 16.04.2024 | Neurolens + The Chris Wolfe Podcast | Dr. Chris Wolfe and Davis Corley 6-part podcast series
April 16, 2024 12:04:15 PM by Neurolens Marke... |
| 08.04.2024 | electroCore Announces the Launch of Truvaga Plus® for Genera... | ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-sta... |
| 02.04.2024 | electroCore Expands Intellectual Property Portfolio | electroCore Granted Two New U.S. Patents
ROCKAWAY, N.J., April 02, 2024 (GLOBE NEWSWIRE) — electroCo... |
| 01.04.2024 | TriSalus Reports Q4 and Full Year 2023 Financial Results and... | DENVER & SALT LAKE CITY–(BUSINESS WIRE)–Apr. 1, 2024– TriSalus Life Sciences Inc., (Nasdaq: TLSI... |
| 27.03.2024 | TriSalus Life Sciences Technology Featured in Two Presentati... | – New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic can... |
| 18.03.2024 | Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023... | CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of... |
| 13.03.2024 | Neurolens Strengthens Leadership for Accelerated Growth and ... | Coppell, Texas — On a mission to transform eye care, Neurolens is pleased to announce a strategic le... |
| 13.03.2024 | electroCore Announces Fourth Quarter and Full Year 2023 Fina... | Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2... |
| 11.03.2024 | TriSalus Life Sciences Announces Q4 Conference Call and Prel... | DENVER–(BUSINESS WIRE)–Mar. 11, 2024– TriSalus Life Sciences® Inc. (Nasdaq: TLSI) announced today th... |
| 07.03.2024 | TriSalus Life Sciences Receives Approval from the World Heal... | – Nelitolimod, a class C TLR-9 agonist formerly called SD-101, is the Company’s therapeutic candidat... |
| 04.03.2024 | Neurolenses Demonstrate Significant Headache Relief | A double-masked, randomized, cross-over clinical study shows that patients wearing Neurolenses had i... |
| 29.02.2024 | TriSalus Life Sciences Announces Real-World Data Demonstrati... | Data published in Current Medical Research and Opinion provide a comparison of the TriNav Infusion S... |
| 27.02.2024 | ATEC Reports Fourth Quarter and Full-Year 2023 Financial Res... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 06.02.2024 | electroCore Expands Intellectual Property Portfolio | ROCKAWAY, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 09.01.2024 | electroCore Expands Intellectual Property Portfolio | ROCKAWAY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 08.01.2024 | ATEC Announces Record Preliminary Revenue Results for 2023 a... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 07.01.2024 | Exagen Inc. Announces Select Preliminary Full-Year 2023 Resu... | CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of ... |
| 26.12.2023 | electroCore Expands Intellectual Property Portfolio | electroCore Granted Two New U.S. Patents |
| 14.12.2023 | TriSalus Life Sciences Announces CMS Reimbursement for the T... | DENVER–(BUSINESS WIRE)–TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating... |
| 12.12.2023 | electroCore Expands Intellectual Property Portfolio for Nerv... | ROCKAWAY, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 14.11.2023 | TriSalus Reports Third Quarter 2023 Financial Results and Pr... | Completed merger with MedTech Acquisition Corporation (MTAC) and started public trading August 11th |
| 13.11.2023 | Exagen Inc. Reports Strong Third Quarter 2023 Results | SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provide... |
| 09.11.2023 | Exagen Inc. and Johns Hopkins University Announce License Ag... | SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provide... |
| 08.11.2023 | electroCore Announces Third Quarter 2023 Financial Results | Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third qu... |
| 07.11.2023 | TriSalus Life Sciences to Host Third Quarter 2023 Financial ... | Call Scheduled for Tuesday, November 14, 2023, at 9:00 a.m. ET |
| 06.11.2023 | ATEC Reports Third Quarter 2023 Financial Results and Raises... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 04.11.2023 | Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Pr... | New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor mic... |
| 03.11.2023 | TriSalus Life Sciences Presents Data for SD-101 Delivered by... | New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor mic... |
| 31.10.2023 | ATEC Equipped to Support Ramping Surgical Volume With Procee... | Positioned to invest in revenue-generating assets as Company continues to capitalize on industry dis... |
| 27.10.2023 | ATEC Announces Closing of Public Stock Offering | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of inn... |
| 25.10.2023 | TriSalus Life Sciences Announces Late Breaker and Additional... | DENVER–(BUSINESS WIRE)–Oct. 25, 2023– TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology comp... |
| 24.10.2023 | ATEC Announces Proposed Public Offering of Common Stock | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of inn... |
| 24.10.2023 | ATEC Announces Pricing of Public Offering of Common Stock | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of inn... |
| 24.10.2023 | Data Highlighting nVNS for Treatment of Gastroparesis Sympto... | Clinical trial suggests nVNS can reduce the use of rescue medications for exacerbations of nausea du... |
| 17.10.2023 | ATEC Enhances Board with Renowned Spine Prowess | Dave Demski appointed to Board of Directors; Keith Valentine appointed Special Advisor to Board of D... |
| 17.10.2023 | electroCore Announces Two-Year Extension of gammaCore™ Devic... | Extension maintains listing through March 17, 2026 |
| 16.10.2023 | ATEC Advances Lateral Surgery With Launch of Expandable Tech... | CARLSBAD, Calif.– (BUSINESS WIRE) — October 16, 2023 — Alphatec Holdings, Inc. (Nasdaq: ATEC), a pro... |
| 16.10.2023 | ATEC Announces Preliminary Third Quarter 2023 Revenue Result... | Total revenue of $117.7 to $118.5 million |
| 11.10.2023 | electroCore Expands Intellectual Property Portfolio for Non-... | ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 10.10.2023 | Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS... | VANQUISH Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache As... |
| 09.10.2023 | ATEC Clinical Precision and Predictability on Display at NAS... | Unleashing 100% spine focus to set the standard in spine care |
| 28.09.2023 | Neurolens Introduces N3 | An immersive, virtual-reality-based measurement and education experience |
| 27.09.2023 | gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improv... | Two prospective, peer-reviewed trials demonstrate the symptomatic benefit of gammaCore in patients w... |
| 26.09.2023 | electroCore Expands Intellectual Property Portfolio for Non-... | ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-sta... |
| 06.09.2023 | TriSalus Life Sciences Appoints Jodi Devlin as President of ... | Devlin Brings Significant Expertise in Commercialization, Sales and Marketing |
| 10.08.2023 | TriSalus Life Sciences Completes Merger with MedTech Acquisi... | DENVER & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Aug. 10, 2023– TriSalus Life Sciences® Inc., (Tri... |
| 09.08.2023 | electroCore Announces Second Quarter 2023 Financial Results | Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second q... |
| 07.08.2023 | Exagen Inc. Reports Strong Second Quarter 2023 Results | SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimm... |
| 03.08.2023 | ATEC Reports Second Quarter 2023 Financial Results and Raise... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 31.07.2023 | electroCore, Inc. Announces $8.145 Million Registered Direct... | ROCKAWAY, N.J., July 31, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or ... |
| 25.07.2023 | gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Impro... | ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 24.07.2023 | Exagen Inc. Appoints Paul Kim to Board of Directors | SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimm... |
| 18.07.2023 | electroCore Expands Intellectual Patent Portfolio for nVNS T... | ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 13.07.2023 | electroCore, Inc. Announces Distribution Agreement with Reli... | ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 11.07.2023 | electroCore Provides Select Second Quarter 2023 Financial Gu... | Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase ov... |
| 06.07.2023 | gammaCore™ Selected for Study Funded by NFL and NFL Players ... | Research grants jointly awarded to independent medical researchers studying alternative pain managem... |
| 27.06.2023 | electroCore’s TAC-STIM™ Non-Invasive Vagal Nerve Stimulation... | ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 12.06.2023 | TriSalus Presents Additional Data for SD-101 Delivered by Pr... | New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor mic... |
| 26.05.2023 | electroCore, Inc. Announces Departure of JP Errico from the ... | ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage... |
| 15.05.2023 | Exagen Inc. Reports First Quarter 2023 Results | Record Physician Demand for AVISE® CTD |
| 04.05.2023 | ATEC Reports First Quarter 2023 Financial Results | CARLSBAD, Calif.–(BUSINESS WIRE)–May 4, 2023– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of ... |
| 03.05.2023 | electroCore Announces First Quarter 2023 Financial Results | Record first quarter 2023 net sales of $2.8 million, approximately 46% over first quarter 2022 |
| 26.04.2023 | National Institutes of Health Awards Grant for Pivotal Clini... | ROCKAWAY, N.J., April 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-sta... |
| 24.04.2023 | Study Presented at 75th Annual Meeting of the American Acade... | Clinical trial (n=36) shows the ability of gammaCore (nVNS) to significantly improve the recall of a... |
| 20.04.2023 | TriSalus Life Sciences Presents New Data at AACR for SD-101 ... | DENVER and FORT LAUDERDALE, Fla., April 20, 2023 – TriSalus Life Sciences® Inc., (“TriSalus” or the ... |
| 20.04.2023 | Neurolens Measures Its One Millionth Patient | DALLAS, April 20, 2023 – Neurolens, a company commercializing innovative solutions to optimize visio... |
| 19.04.2023 | ATEC Announces $60 Million Underwritten Offering | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 19.04.2023 | ATEC Acquires Navigation-Enabled Robotics Platform; Raises 2... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 17.04.2023 | electroCore Provides Select First Quarter 2023 Financial Gui... | ROCKAWAY, N.J., April 17, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”) (Nasdaq: ECOR), ... |
| 12.04.2023 | electroCore Expands Intellectual Patent Portfolio for nVNS T... | electroCore Granted Three New U.S. Patents |
| 06.04.2023 | electroCore, Inc. Announces Product Registration in Indonesi... | ROCKAWAY, N.J., April 06, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR),... |
| 04.04.2023 | electroCore, Inc. Announces gammaCore Non-Invasive Vagus Ner... | ROCKAWAY, N.J., April 04, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR),... |
| 23.03.2023 | electroCore Reports Results of Pre-Clinical Trial in a Model... | Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease... |
| 21.03.2023 | electroCore’s Truvaga Users Reported Improved Stress, Anxiet... | ROCKAWAY, N.J., March 21, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR),... |
| 20.03.2023 | Exagen Inc. Reports Fourth Quarter and Full Year 2022 Result... | Record AVISE® CTD Volume in 2022 |
| 08.03.2023 | electroCore Announces Fourth Quarter and Full Year 2022 Fina... | Record full year 2022 net sales of $8.6 million increased 58% over $5.5 million for full year 2021 |
| 28.02.2023 | ATEC Reports Record Fourth Quarter and Full-Year 2022 Financ... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 21.02.2023 | TriSalus Life Sciences Appoints James Alecxih to Lead Device... | DENVER and CHICAGO, February 21, 2023 – TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”),... |
| 21.02.2023 | electroCore, Inc. Announces Exclusive Distribution Agreement... | ROCKAWAY, N.J., Feb. 21, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), ... |
| 16.02.2023 | TriSalus Life Sciences Posts Updated Investor Presentation H... | Data Further Supports the Potential of the Company’s Therapeutic Platform to Improve Immunotherapy O... |
| 16.02.2023 | electroCore Expands Intellectual Patent Portfolio for nVNS T... | ROCKAWAY, N.J., Feb. 16, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 14.02.2023 | electroCore Announces Reverse Stock Split | ROCKAWAY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a... |
| 23.01.2023 | Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of... | SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimm... |
| 17.01.2023 | electroCore Announces Expected Record 4Q 2022 Revenue of $2.... | ROCKAWAY, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a... |
| 09.01.2023 | ATEC Announces Select Preliminary Financial 2022 Results, 20... | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 20.12.2022 | electroCore, Inc. Launches New Wellness Product Offering for... | Truvaga™ handheld non-invasive vagus nerve stimulator offers drug-free 2-minute sessions |
| 15.12.2022 | TriSalus Life Sciences Highlights Pressure-Enabled Regional ... | Studies evaluating methods to overcome two major challenges in treating patients with liver and panc... |
| 07.12.2022 | electroCore Announces Issuance of Two New U.S. Patents | Expansion of patent portfolio allows exploration of the role of nVNS beyond migraine and cluster hea... |
| 20.11.2022 | TriSalus Life Sciences Provides Updates on Pressure-Enabled ... | Data further substantiates potential to significantly improve immunotherapy outcomes for patients wi... |
| 18.11.2022 | gammaCore Sapphire™ Non-Invasive Vagus Nerve Stimulator (nVN... | ROCKAWAY, N.J., Nov. 18, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), ... |
| 14.11.2022 | TriSalus Life Sciences to Become Publicly Traded Through Mer... | Oncology Therapeutics Company Focused on Transforming Cancer Treatment with Proprietary Innovative T... |
| 14.11.2022 | Exagen Inc. Reports Third Quarter 2022 Results | Medicare Reimbursement Returns |
| 03.11.2022 | electroCore Announces Third Quarter 2022 Financial Results | Third quarter 2022 revenue grew 33% over third quarter 2021 |
| 03.11.2022 | ATEC Reports Third Quarter 2022 Financial Results | CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative s... |
| 01.11.2022 | electroCore, Inc. Announces Distribution Agreement with Joer... | ROCKAWAY, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stag... |
| 20.10.2022 | gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improv... | Pre-clinical trial demonstrates ability of nVNS to decrease amount of brain injury, decrease anxiety... |